[
  {
    "ts": "2026-01-22T00:02:43+00:00",
    "headline": "J&J's Guidance Wallops Views, But Boston Scientific, Medtronic Take A Toll",
    "summary": "Johnson & Johnson stock dipped Wednesday despite a fourth-quarter beat as Medtronic and Boston Scientific continued gaining share in PFA.",
    "url": "https://www.investors.com/news/technology/johnson-and-johnson-stock-jnj-earnings-q4-2025/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "2a14968b-af49-395f-8455-489539a6620c",
      "content": {
        "id": "2a14968b-af49-395f-8455-489539a6620c",
        "contentType": "STORY",
        "title": "J&J's Guidance Wallops Views, But Boston Scientific, Medtronic Take A Toll",
        "description": "",
        "summary": "Johnson & Johnson stock dipped Wednesday despite a fourth-quarter beat as Medtronic and Boston Scientific continued gaining share in PFA.",
        "pubDate": "2026-01-22T00:02:43Z",
        "displayTime": "2026-01-22T00:02:43Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/2a14968b-af49-395f-8455-489539a6620c/j-j-s-guidance-wallops-views-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/0ae2b2db37883f68ee2069be9bd594e4",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rwA2Kba4.xjpNvtEg7n9QQ--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/0ae2b2db37883f68ee2069be9bd594e4.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9I9e__rmE38egilIIeIqrQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/0ae2b2db37883f68ee2069be9bd594e4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/johnson-and-johnson-stock-jnj-earnings-q4-2025/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "MDT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-22T08:09:21+00:00",
    "headline": "Jim Cramer on Honeywell: “It’s Finally Getting Credit for All the Things It’s Doing”",
    "summary": "Honeywell International Inc. (NASDAQ:HON) is one of the stocks Jim Cramer recently looked at. A caller mentioned that their top five holdings are ABBV, HON, ET, SAN, and MDT during the round of “Am I Diversified.” Here’s what Cramer had to say in response: Oh wow. What a fantastic list. Okay, Medtronic, we know is […]",
    "url": "https://finance.yahoo.com/news/jim-cramer-honeywell-finally-getting-080921829.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "a5209b9f-26f6-38f1-8ad2-1be1ee1ad3f0",
      "content": {
        "id": "a5209b9f-26f6-38f1-8ad2-1be1ee1ad3f0",
        "contentType": "STORY",
        "title": "Jim Cramer on Honeywell: “It’s Finally Getting Credit for All the Things It’s Doing”",
        "description": "",
        "summary": "Honeywell International Inc. (NASDAQ:HON) is one of the stocks Jim Cramer recently looked at. A caller mentioned that their top five holdings are ABBV, HON, ET, SAN, and MDT during the round of “Am I Diversified.” Here’s what Cramer had to say in response: Oh wow. What a fantastic list. Okay, Medtronic, we know is […]",
        "pubDate": "2026-01-22T08:09:21Z",
        "displayTime": "2026-01-22T08:09:21Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/f4972b23ca1d429713741721f81c5f25",
          "originalWidth": 1920,
          "originalHeight": 1280,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RcFryqOLWXyjpn.bSexpBA--~B/aD0xMjgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/f4972b23ca1d429713741721f81c5f25.cf.webp",
              "width": 1920,
              "height": 1280,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/11C66UWKw4HJJjHboXfTPw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/f4972b23ca1d429713741721f81c5f25.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-honeywell-finally-getting-080921829.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-honeywell-finally-getting-080921829.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HON"
            },
            {
              "symbol": "MDT"
            },
            {
              "symbol": "ET"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "SAN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-22T08:09:13+00:00",
    "headline": "Jim Cramer on GE HealthCare: “I Just Don’t Think It’s What You Want to Own”",
    "summary": "GE HealthCare Technologies Inc. (NASDAQ:GEHC) is one of the stocks Jim Cramer recently looked at. Noting that they own 83 shares of GEHC, a caller asked if they should sell their position. In response, Cramer said: Okay, I worked for GE, so I got, I’m not allowed to own stock. I want to make that […]",
    "url": "https://finance.yahoo.com/news/jim-cramer-ge-healthcare-just-080913902.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "4adf584e-3a64-3e76-a643-8270fd755fc5",
      "content": {
        "id": "4adf584e-3a64-3e76-a643-8270fd755fc5",
        "contentType": "STORY",
        "title": "Jim Cramer on GE HealthCare: “I Just Don’t Think It’s What You Want to Own”",
        "description": "",
        "summary": "GE HealthCare Technologies Inc. (NASDAQ:GEHC) is one of the stocks Jim Cramer recently looked at. Noting that they own 83 shares of GEHC, a caller asked if they should sell their position. In response, Cramer said: Okay, I worked for GE, so I got, I’m not allowed to own stock. I want to make that […]",
        "pubDate": "2026-01-22T08:09:13Z",
        "displayTime": "2026-01-22T08:09:13Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/92264ef32b70332cc4ea9283d978e1a6",
          "originalWidth": 6538,
          "originalHeight": 4359,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RYQ.uW7wwp9a4kdxC.OBbQ--~B/aD00MzU5O3c9NjUzODthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/92264ef32b70332cc4ea9283d978e1a6.cf.webp",
              "width": 6538,
              "height": 4359,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2i4a98C_B2YJXhctyiN1Vw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/92264ef32b70332cc4ea9283d978e1a6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-ge-healthcare-just-080913902.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-ge-healthcare-just-080913902.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GEHC"
            },
            {
              "symbol": "MDT"
            },
            {
              "symbol": "GEV"
            },
            {
              "symbol": "ABT"
            },
            {
              "symbol": "GE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-22T10:41:00+00:00",
    "headline": "Want Decades of Passive Income? 2 Stocks to Buy Right Now.",
    "summary": "Their dividend streaks speak volumes.",
    "url": "https://www.fool.com/investing/2026/01/22/want-decades-of-passive-income-2-stocks-to-buy/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "e95bd0dd-7049-3818-9b90-ace90aea47a3",
      "content": {
        "id": "e95bd0dd-7049-3818-9b90-ace90aea47a3",
        "contentType": "STORY",
        "title": "Want Decades of Passive Income? 2 Stocks to Buy Right Now.",
        "description": "",
        "summary": "Their dividend streaks speak volumes.",
        "pubDate": "2026-01-22T10:41:00Z",
        "displayTime": "2026-01-22T10:41:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/7c51b582c2a8832edae5dd73b95511e9",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "Physicians in an operating room operating on a patient.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RZLbN8vhD0MTvHrRTfRymQ--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/7c51b582c2a8832edae5dd73b95511e9.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IbYdb95iCRfX_P0Q4mYeqw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/7c51b582c2a8832edae5dd73b95511e9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/01/22/want-decades-of-passive-income-2-stocks-to-buy/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/want-decades-passive-income-2-104100228.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MDT"
            },
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-22T15:03:51+00:00",
    "headline": "What to Expect From Medtronic's Next Quarterly Earnings Report",
    "summary": "Medtronic is expected to announce its fiscal third-quarter earnings next month, and analysts project a single-digit profit drop.",
    "url": "https://www.barchart.com/story/news/37175883/what-to-expect-from-medtronic-s-next-quarterly-earnings-report",
    "source": "Barchart",
    "provider": "yfinance",
    "raw": {
      "id": "109724a6-edce-30e8-b0d6-a7264d51d48d",
      "content": {
        "id": "109724a6-edce-30e8-b0d6-a7264d51d48d",
        "contentType": "STORY",
        "title": "What to Expect From Medtronic's Next Quarterly Earnings Report",
        "description": "",
        "summary": "Medtronic is expected to announce its fiscal third-quarter earnings next month, and analysts project a single-digit profit drop.",
        "pubDate": "2026-01-22T15:03:51Z",
        "displayTime": "2026-01-22T15:03:51Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/barchart_com_477/7dd54cfc17e6b94ed1e6ae999610b4db",
          "originalWidth": 1254,
          "originalHeight": 836,
          "caption": "Medtronic Plc HQ-by JHVEPhoto via iStock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RTshAwpHgczgVihrXXyL2Q--~B/aD04MzY7dz0xMjU0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/barchart_com_477/7dd54cfc17e6b94ed1e6ae999610b4db.cf.webp",
              "width": 1254,
              "height": 836,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/P2rUzkZAKTQSq9JLoDQ7QA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/barchart_com_477/7dd54cfc17e6b94ed1e6ae999610b4db.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barchart",
          "url": "https://www.barchart.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barchart.com/story/news/37175883/what-to-expect-from-medtronic-s-next-quarterly-earnings-report",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/expect-medtronics-next-quarterly-earnings-150351911.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MDT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-22T21:02:00+00:00",
    "headline": "Anteris Announces Strategic Investment from Medtronic to Continue Advancing TAVR in $320 Million Aggregate Capital Raises",
    "summary": "MINNEAPOLIS and BRISBANE, Australia, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, announced today it has completed a $90 million strategic investment from Medtronic, plc (Galway, Ireland) (NASDAQ: MDT) (Medtronic), the world’s largest medical technology company. The investm",
    "url": "https://finance.yahoo.com/news/anteris-announces-strategic-investment-medtronic-210200913.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "0a2b926b-a872-32e8-aa1d-be13cfc1d47e",
      "content": {
        "id": "0a2b926b-a872-32e8-aa1d-be13cfc1d47e",
        "contentType": "STORY",
        "title": "Anteris Announces Strategic Investment from Medtronic to Continue Advancing TAVR in $320 Million Aggregate Capital Raises",
        "description": "",
        "summary": "MINNEAPOLIS and BRISBANE, Australia, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, announced today it has completed a $90 million strategic investment from Medtronic, plc (Galway, Ireland) (NASDAQ: MDT) (Medtronic), the world’s largest medical technology company. The investm",
        "pubDate": "2026-01-22T21:02:00Z",
        "displayTime": "2026-01-22T21:02:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/69fe00e2d9b27260d0d2d76ea4461057",
          "originalWidth": 1789,
          "originalHeight": 492,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Ats66grZ82kNbQ3KqXoJtQ--~B/aD00OTI7dz0xNzg5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/69fe00e2d9b27260d0d2d76ea4461057.cf.webp",
              "width": 1789,
              "height": 492,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Dt_J.HxcSSMkU2.3jqHjyA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/69fe00e2d9b27260d0d2d76ea4461057.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/anteris-announces-strategic-investment-medtronic-210200913.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/anteris-announces-strategic-investment-medtronic-210200913.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AVR"
            },
            {
              "symbol": "MDT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-22T21:01:00+00:00",
    "headline": "Anteris Technologies Global Corp. Announces Closing of $230 Million Public Offering of Common Stock",
    "summary": "MINNEAPOLIS and BRISBANE, Australia, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR), a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today announced the closing of its underwritten public offering (the “Offering”) of 40,000,000 shares of its common stock, including the exercise in full of the underwriters’ option to pu",
    "url": "https://finance.yahoo.com/news/anteris-technologies-global-corp-announces-210100173.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "c79b6eb4-dfdd-3d23-9511-1c8aed0a1a9e",
      "content": {
        "id": "c79b6eb4-dfdd-3d23-9511-1c8aed0a1a9e",
        "contentType": "STORY",
        "title": "Anteris Technologies Global Corp. Announces Closing of $230 Million Public Offering of Common Stock",
        "description": "",
        "summary": "MINNEAPOLIS and BRISBANE, Australia, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR), a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today announced the closing of its underwritten public offering (the “Offering”) of 40,000,000 shares of its common stock, including the exercise in full of the underwriters’ option to pu",
        "pubDate": "2026-01-22T21:01:00Z",
        "displayTime": "2026-01-22T21:01:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/69fe00e2d9b27260d0d2d76ea4461057",
          "originalWidth": 1789,
          "originalHeight": 492,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Ats66grZ82kNbQ3KqXoJtQ--~B/aD00OTI7dz0xNzg5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/69fe00e2d9b27260d0d2d76ea4461057.cf.webp",
              "width": 1789,
              "height": 492,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Dt_J.HxcSSMkU2.3jqHjyA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/69fe00e2d9b27260d0d2d76ea4461057.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/anteris-technologies-global-corp-announces-210100173.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/anteris-technologies-global-corp-announces-210100173.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AVR"
            },
            {
              "symbol": "MDT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-22T22:50:05+00:00",
    "headline": "Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know",
    "summary": "Medtronic (MDT) closed the most recent trading day at $101.34, moving +1.05% from the previous trading session.",
    "url": "https://finance.yahoo.com/news/medtronic-mdt-outpaces-stock-market-225005803.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "eb1e97b4-dbf5-3203-8aae-720fc040d7fd",
      "content": {
        "id": "eb1e97b4-dbf5-3203-8aae-720fc040d7fd",
        "contentType": "STORY",
        "title": "Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know",
        "description": "",
        "summary": "Medtronic (MDT) closed the most recent trading day at $101.34, moving +1.05% from the previous trading session.",
        "pubDate": "2026-01-22T22:50:05Z",
        "displayTime": "2026-01-22T22:50:05Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/45c083e4721b0d0d1f6e431ec0bb5cc1",
          "originalWidth": 900,
          "originalHeight": 602,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tLc26fx9TJ6VqGsh8AFf8w--~B/aD02MDI7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/45c083e4721b0d0d1f6e431ec0bb5cc1.cf.webp",
              "width": 900,
              "height": 602,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/G.EHzHXMwORhvPQ5KT6TdQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/45c083e4721b0d0d1f6e431ec0bb5cc1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/medtronic-mdt-outpaces-stock-market-225005803.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/medtronic-mdt-outpaces-stock-market-225005803.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MDT"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^DJI"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-22T16:28:46+00:00",
    "headline": "Anteris Technologies announces $200M public offering to fund clinical growth",
    "summary": "Anteris Technologies CEO Wayne Paterson joined Steve Darling from Proactive to announce that the company has launched a proposed underwritten public offering of $200 million of its common stock, subject to market and other customary conditions. In connection with the offering, Anteris also plans to grant the underwriters a 30-day option to purchase up to an additional $30 million of common stock at the public offering price. Paterson also confirmed that Anteris has entered into a private placement agreement with Medtronic plc, further strengthening the company’s balance sheet and strategic positioning. The net proceeds from the public offering, together with existing cash and cash equivalents and the proceeds from the private placement, are expected to support the next phase of the company’s growth and the continued execution of its clinical and operational strategy. The company intends to use the funds to advance the ongoing global pivotal trial of its DurAVR® Transcatheter Heart Valve for patients with severe aortic stenosis. The PARADIGM Trial is currently focused on patient recruitment and study execution, and represents a key step toward potential regulatory approval of the DurAVR® THV. In addition, Anteris plans to expand its manufacturing capabilities to support future commercialization. A portion of the proceeds is also expected to fund continued research and development activities at v2vmedtech, inc., while the remaining capital will be allocated to working capital and other general corporate purposes as determined by management from time to time. Anteris Technologies is a global structural heart company dedicated to the design, development, and commercialization of advanced medical devices aimed at restoring healthy heart function. Founded in Australia with a significant operational presence in Minneapolis, Minnesota, the company is science-driven and supported by a multidisciplinary team with deep expertise in structural heart disease. The company’s lead product, the DurAVR® THV, was developed in collaboration with leading interventional cardiologists and cardiac surgeons worldwide to treat aortic stenosis, a potentially life-threatening condition caused by narrowing of the aortic valve. Anteris believes the DurAVR® THV has the potential to offer meaningful clinical benefits for patients suffering from this serious condition. He also discussed recent clinical data presented at the London Valve conference, spotlighting a dramatic reduction in patient-prosthetic mismatch (PPM) rates with DurAVR compared to the market leader—3% versus 30%. #proactiveinvestors #anteristechnologiesglobalcorp #asx #avr #nasdaq #avr #PublicOffering #MedTech #StructuralHeart #DurAVR #TranscatheterValve #AorticStenosis #ClinicalTrials #PARADIGMTrial #MedicalDevices #HealthcareInnovation #BiotechNews #Cardiology #HeartHealth #LifeSciences",
    "url": "https://finance.yahoo.com/video/anteris-technologies-announces-200m-public-162846610.html",
    "source": "Proactive",
    "provider": "yfinance",
    "raw": {
      "id": "71a7d29f-1372-393b-89e2-ea99cff1a684",
      "content": {
        "id": "71a7d29f-1372-393b-89e2-ea99cff1a684",
        "contentType": "VIDEO",
        "title": "Anteris Technologies announces $200M public offering to fund clinical growth",
        "description": "Anteris Technologies CEO Wayne Paterson joined Steve Darling from Proactive to announce that the company has launched a proposed underwritten public offering of $200 million of its common stock, subject to market and other customary conditions. In connection with the offering, Anteris also plans to grant the underwriters a 30-day option to purchase up to an additional $30 million of common stock at the public offering price.\n\nPaterson also confirmed that Anteris has entered into a private placement agreement with Medtronic plc, further strengthening the company’s balance sheet and strategic positioning. The net proceeds from the public offering, together with existing cash and cash equivalents and the proceeds from the private placement, are expected to support the next phase of the company’s growth and the continued execution of its clinical and operational strategy.\n\nThe company intends to use the funds to advance the ongoing global pivotal trial of its DurAVR® Transcatheter Heart Valve for patients with severe aortic stenosis. The PARADIGM Trial is currently focused on patient recruitment and study execution, and represents a key step toward potential regulatory approval of the DurAVR® THV. In addition, Anteris plans to expand its manufacturing capabilities to support future commercialization.\n\nA portion of the proceeds is also expected to fund continued research and development activities at v2vmedtech, inc., while the remaining capital will be allocated to working capital and other general corporate purposes as determined by management from time to time.\n\nAnteris Technologies is a global structural heart company dedicated to the design, development, and commercialization of advanced medical devices aimed at restoring healthy heart function. Founded in Australia with a significant operational presence in Minneapolis, Minnesota, the company is science-driven and supported by a multidisciplinary team with deep expertise in structural heart disease.\n\nThe company’s lead product, the DurAVR® THV, was developed in collaboration with leading interventional cardiologists and cardiac surgeons worldwide to treat aortic stenosis, a potentially life-threatening condition caused by narrowing of the aortic valve. Anteris believes the DurAVR® THV has the potential to offer meaningful clinical benefits for patients suffering from this serious condition. He also discussed recent clinical data presented at the London Valve conference, spotlighting a dramatic reduction in patient-prosthetic mismatch (PPM) rates with DurAVR compared to the market leader—3% versus 30%.\n\n#proactiveinvestors #anteristechnologiesglobalcorp #asx #avr #nasdaq #avr #PublicOffering #MedTech #StructuralHeart #DurAVR #TranscatheterValve #AorticStenosis #ClinicalTrials #PARADIGMTrial #MedicalDevices #HealthcareInnovation #BiotechNews #Cardiology #HeartHealth #LifeSciences",
        "summary": "Anteris Technologies CEO Wayne Paterson joined Steve Darling from Proactive to announce that the company has launched a proposed underwritten public offering of $200 million of its common stock, subject to market and other customary conditions. In connection with the offering, Anteris also plans to grant the underwriters a 30-day option to purchase up to an additional $30 million of common stock at the public offering price. Paterson also confirmed that Anteris has entered into a private placement agreement with Medtronic plc, further strengthening the company’s balance sheet and strategic positioning. The net proceeds from the public offering, together with existing cash and cash equivalents and the proceeds from the private placement, are expected to support the next phase of the company’s growth and the continued execution of its clinical and operational strategy. The company intends to use the funds to advance the ongoing global pivotal trial of its DurAVR® Transcatheter Heart Valve for patients with severe aortic stenosis. The PARADIGM Trial is currently focused on patient recruitment and study execution, and represents a key step toward potential regulatory approval of the DurAVR® THV. In addition, Anteris plans to expand its manufacturing capabilities to support future commercialization. A portion of the proceeds is also expected to fund continued research and development activities at v2vmedtech, inc., while the remaining capital will be allocated to working capital and other general corporate purposes as determined by management from time to time. Anteris Technologies is a global structural heart company dedicated to the design, development, and commercialization of advanced medical devices aimed at restoring healthy heart function. Founded in Australia with a significant operational presence in Minneapolis, Minnesota, the company is science-driven and supported by a multidisciplinary team with deep expertise in structural heart disease. The company’s lead product, the DurAVR® THV, was developed in collaboration with leading interventional cardiologists and cardiac surgeons worldwide to treat aortic stenosis, a potentially life-threatening condition caused by narrowing of the aortic valve. Anteris believes the DurAVR® THV has the potential to offer meaningful clinical benefits for patients suffering from this serious condition. He also discussed recent clinical data presented at the London Valve conference, spotlighting a dramatic reduction in patient-prosthetic mismatch (PPM) rates with DurAVR compared to the market leader—3% versus 30%. #proactiveinvestors #anteristechnologiesglobalcorp #asx #avr #nasdaq #avr #PublicOffering #MedTech #StructuralHeart #DurAVR #TranscatheterValve #AorticStenosis #ClinicalTrials #PARADIGMTrial #MedicalDevices #HealthcareInnovation #BiotechNews #Cardiology #HeartHealth #LifeSciences",
        "pubDate": "2026-01-22T16:28:46Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/proactive_video_751/106e273fece369cff0bf4182cd528bb1",
          "originalWidth": 1920,
          "originalHeight": 1080,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zMykildOnWgZeUf2d082UQ--~B/aD0xMDgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/proactive_video_751/106e273fece369cff0bf4182cd528bb1.cf.webp",
              "width": 1920,
              "height": 1080,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6XUUjQvcVDrqXaLo5drQsw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/proactive_video_751/106e273fece369cff0bf4182cd528bb1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Proactive",
          "url": "https://www.proactiveinvestors.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/anteris-technologies-announces-200m-public-162846610.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/anteris-technologies-announces-200m-public-162846610.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AVR"
            },
            {
              "symbol": "MDT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]